Mount Sinai Heart leader will be recognized for his exceptional achievements at the 71st annual conference
A new drug shows promise in providing relief to hypertrophic cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.
A new type of anti-clotting drug caused fewer bleeding incidents among patients with atrial fibrillation than the commonly prescribed apixaban, according to results from a head-to-head comparison of the two.
Medicare patients whose implantable heart devices became infected were less likely to die from the complication if they had the hardware removed compared to patients who only received antibiotics, according to the largest study on the topic, led by the Duke Clinical Research Institute.
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.
Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental “gene silencing” therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%. Findings from the “APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial” were presented today during a late-breaking science session at American College of Cardiology’s 71st Annual Scientific Session and simultaneously published online in the Journal of the American Medical Association.
The Los Angeles Barbershop Blood Pressure Study is delivering cutting-edge insights more than four years after the study results were published in The New England Journal of Medicine.
Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.
Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.
New research finds potential for high-resistance inspiratory muscle strength training to help sedentary middle-aged and older adults transition to a healthier lifestyle. The study will be presented this week at the American Physiological Society annual meeting at Experimental Biology 2022.
New research finds that excess caffeine is more likely to cause irregular heart rhythms in middle aged rats than in young adult rats. The study will be presented this week at the American Physiological Society annual meeting at Experimental Biology 2022 in Philadelphia.
Researchers have successfully used a virtual population to replicate a clinical trial that examined kidney damage in Black Americans, according to a new study at the University of Mississippi Medical Center in Jackson.
Michelle Kittleson, MD, PhD, Director of Post-Graduate Education in Heart Failure and Transplantation and Director of Heart Failure Research in the Smidt Heart Institute, Can Discuss New Clinical Guidance
A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease, according to a new study published in PLOS ONE by researchers from the University of Eastern Finland together with international collaborators.
Fluctuations in body weight resulting from drastically cutting and increasing calories may lead to physiological changes that raise the risk of heart disease or diabetes later in life, according to a study being presented at the American Physiological Society annual meeting during the Experimental Biology (EB) 2022 meeting, held in Philadelphia April 2–5.
This tipsheet highlights the latest medical discoveries and faculty news at Cedars-Sinai. Links to full news releases are included with each tipsheet item.
Background: Cardiac rehabilitation is central in reducing mortality and morbidity after myocardial infarction. However, the fulfillment of guideline-recommended cardiac rehabilitation targets is unsatisfactory. eHealth offers new pos...
在全球范围内，糖尿病患者的数量正不断增加，且糖尿病患者发生心脏疾病的风险较高于一般人群。Gosia Wamil医学博士/哲学博士作为妙佑伦敦医疗中心（Mayo Clinic Healthcare in London）的一名心脏病学家，解释了这两种严重、慢性疾病之间的联系。
O número mundial de pessoas com diabetes está aumentando, e com ela há um risco maior de doença cardíaca. Gosia Wamil, M.D., Ph.D., cardiologista na Mayo Clinic Healthcare em Londres, explica a conexão entre essas duas doenças crônicas graves.
Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right